Literature DB >> 15692807

A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Tarik Belhocine, Stefan Markus Weiner, Ingo Brink, Peter Paul De Deyn, Jan Roland, Thierry Van der Borght, Patrick Flamen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15692807     DOI： 10.1007/s00259-004-1729-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  54 in total

1.  Cerebral angio- and neuro-Behçet's syndrome: neuroradiological and pathological study of one case.

Authors:  M Nishimura; K Satoh; M Suga; M Oda
Journal:  J Neurol Sci       Date:  1991-11       Impact factor: 3.181

2.  Limbic encephalitis: comparison of FDG PET and MR imaging findings.

Authors:  J M Provenzale; D P Barboriak; R E Coleman
Journal:  AJR Am J Roentgenol       Date:  1998-06       Impact factor: 3.959

Review 3.  18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective.

Authors:  M Schirmer; K T Calamia; M Wenger; A Klauser; C Salvarani; R Moncayo
Journal:  Exp Gerontol       Date:  2003-04       Impact factor: 4.032

4.  FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.

Authors:  J M Hoffman; H A Waskin; T Schifter; M W Hanson; L Gray; S Rosenfeld; R E Coleman
Journal:  J Nucl Med       Date:  1993-04       Impact factor: 10.057

5.  Limbic encephalitis and hyperactive foci on PET scan.

Authors:  T Fakhoury; B Abou-Khalil; R M Kessler
Journal:  Seizure       Date:  1999-10       Impact factor: 3.184

6.  A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.

Authors:  Miroslawa Nowak; Jorge A Carrasquillo; Cheryl H Yarboro; Steven L Bacharach; Millie Whatley; Xavier Valencia; Kazuki Takada; Douglas G Brust; Gabor G Illei
Journal:  Arthritis Rheum       Date:  2004-04

7.  18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

Authors:  Alexander M Spence; Mark Muzi; David A Mankoff; S Finbarr O'Sullivan; Jeanne M Link; Thomas K Lewellen; Barbara Lewellen; Pam Pham; Satoshi Minoshima; Kristin Swanson; Kenneth A Krohn
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

8.  2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in systemic lupus erythematosus-associated adenopathy.

Authors:  Geoffrey L Fey; Paul R Jolles; Lenore M Buckley; Gita V Massey
Journal:  Mol Imaging Biol       Date:  2004 Jan-Feb       Impact factor: 3.488

9.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.

Authors:  Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544

Review 10.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.